No Data
No Data
No Data
ST Sansheng (002742.SZ): The company's pharmaceutical products do not involve synthetic biology
Gelonghui, May 15 | ST Sansheng (002742.SZ) said on the investor interactive platform that the company's pharmaceutical products do not involve synthetic biology.
ST Sansheng (002742.SZ) received a decision on corrective measures ordered by the Chongqing Securities Regulatory Bureau
Zhitong Finance App News, ST Sansheng (002742.SZ) announced that the company received the “Decision on Administrative Supervision Measures” issued by the China Securities Regulatory Commission and the Chongqing Securities Regulatory Bureau on May 10, 2024. The Chongqing Securities Regulatory Bureau decided to take corrective administrative supervision measures against the company and Pan Xianwen. According to the announcement, according to Chapter 9, Section 4 of the “Shenzhen Stock Exchange Stock Listing Rules (2024 Revision)”, if the company fails to clear 113 million yuan of occupied capital and interest within six months in accordance with the requirements of the ordered corrective measures, the Shenzhen Stock Exchange will suspend trading of the company's shares, and not within two months after the suspension
ST Sansheng (002742.SZ) reported first-quarter results with a net loss of 354.16,900 yuan
According to Zhitong Finance App, ST Sansheng (002742.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 348 million yuan, a year-on-year decrease of 30.01%; net loss attributable to shareholders of listed companies was 354.16,900 yuan; net loss attributable to shareholders of listed companies was deducted from non-recurring profit and loss of 308.224 million yuan per share; basic loss per share.
Chongqing Sansheng Industrial Co.,Ltd. (SZSE:002742) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Chongqing Sansheng Industrial Co.,Ltd. (SZSE:002742) shares are down a considerable 27% in the last month, which continues a horrid run for the company. Inste
ST Sansheng (002742.SZ) issued an advance loss and is expected to have a net loss of 360 million yuan to 465 million yuan in 2023
ST Sansheng (002742.SZ) announced the 2023 annual results forecast, which is expected to be net attributable to shareholders of listed companies...
Pan Xianwen, the actual controller of ST Sansheng (002742.SZ), was sentenced for manipulating the securities market and issuing shares without permission
ST Sansheng (002742.SZ) announced that the company recently received the Chongqing No. 1 delivered by Pan Xianwen, the company's actual controller...
No Data